miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3

BACKGROUND AND OBJECTIVES: The roles of microRNA(miR)‐106b‐5p in hepatocellular carcinoma (HCC) remain unclear. We aimed here to investigate the clinical significance of miR‐106b‐5p expression in HCC and its underlying mechanisms. METHODS: Expression levels of miR‐106b‐5p in 108 HCC clinical samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Hao, Gu, Shensen, Zhang, Xinlong, Zhang, Songjiang, Zhang, Dongming, Lin, Junsheng, Hasengbayi, Saiken, Han, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825988/
https://www.ncbi.nlm.nih.gov/pubmed/31503422
http://dx.doi.org/10.1002/cam4.2511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825988/
https://www.ncbi.nlm.nih.gov/pubmed/31503422
http://dx.doi.org/10.1002/cam4.2511

Ejemplares similares